Search research articles
Contact Us
Filters
Showing results (201-210 of 367) with videos related to
Page
of 37
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 22, 2006
Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer
Luis Paz-Ares, Jean-Yves Douillard, Piotr Koralewski, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 16, 2013
Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients
Marlies E Heuvers, Femke Muskens, Koen Bezemer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2019
Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non-small Cell Lung Cancer Patients
Pauline L de Goeje, Myrthe Poncin, Koen Bezemer, et al.
Frontiers in Oncology
|
February 7, 2024
Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus report
Myriam Mirza, Aseem Shrivastava, Cecile Matthews, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 23, 2016
Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib
Vivian E M van den Boogaart, Quido G de Lussanet, Ruud M A Houben, et al.
Molecular Oncology
|
November 27, 2023
Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancer
Franziska Böttger, Teodora Radonic, Idris Bahce, et al.
Nature Medicine
|
August 10, 2021
Limited evolution of the actionable metastatic cancer genome under therapeutic pressure
Joris van de Haar, Louisa R Hoes, Paul Roepman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2006
Quality assurance of thoracic radiotherapy in EORTC 08941: a randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapy
Gijsbert W P M Kramer, Catherine L Legrand, Paul van Schil, et al.
Arthritis Research & Therapy
|
April 16, 2011
Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study
Maria J Overbeek, Anco Boonstra, Alexandre E Voskuyl, et al.
BMC Cancer
|
May 12, 2012
Stepped care targeting psychological distress in head and neck and lung cancer patients: a randomized clinical trial
Anne-Marie H Krebber, C René Leemans, Remco de Bree, et al.
Page
of 37
Search research articles
Search
Showing results (201-210 of 367) with videos related to
Sort By:
Page
of 37
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 22, 2006
Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer
Luis Paz-Ares, Jean-Yves Douillard, Piotr Koralewski, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 16, 2013
Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients
Marlies E Heuvers, Femke Muskens, Koen Bezemer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2019
Induction of Peripheral Effector CD8 T-cell Proliferation by Combination of Paclitaxel, Carboplatin, and Bevacizumab in Non-small Cell Lung Cancer Patients
Pauline L de Goeje, Myrthe Poncin, Koen Bezemer, et al.
Frontiers in Oncology
|
February 7, 2024
Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus report
Myriam Mirza, Aseem Shrivastava, Cecile Matthews, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 23, 2016
Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib
Vivian E M van den Boogaart, Quido G de Lussanet, Ruud M A Houben, et al.
Molecular Oncology
|
November 27, 2023
Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancer
Franziska Böttger, Teodora Radonic, Idris Bahce, et al.
Nature Medicine
|
August 10, 2021
Limited evolution of the actionable metastatic cancer genome under therapeutic pressure
Joris van de Haar, Louisa R Hoes, Paul Roepman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2006
Quality assurance of thoracic radiotherapy in EORTC 08941: a randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapy
Gijsbert W P M Kramer, Catherine L Legrand, Paul van Schil, et al.
Arthritis Research & Therapy
|
April 16, 2011
Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study
Maria J Overbeek, Anco Boonstra, Alexandre E Voskuyl, et al.
BMC Cancer
|
May 12, 2012
Stepped care targeting psychological distress in head and neck and lung cancer patients: a randomized clinical trial
Anne-Marie H Krebber, C René Leemans, Remco de Bree, et al.
Page
of 37